U.S. Beverage Stock News

AnaptysBio recently filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court, while a trial covering all remaining issues in their collaboration dispute is scheduled for July 14–17, 2026. The company has also announced plans to separate its biopharma operations from its sizeable royalty assets by the end of 2026, signaling a potential shift in how investors assess its underlying business drivers. We will now examine how AnaptysBio’s plan to...

Why SIGA is back on investors’ radar SIGA Technologies (SIGA) is drawing fresh attention after recent coverage highlighted its TPOXX smallpox antiviral, consistent profitability, and solid balance sheet, even as major new contract or regulatory announcements remain quiet. See our latest analysis for SIGA Technologies. At a share price of US$6.77, SIGA has seen a 10.8% 7 day share price return and an 8.3% 30 day share price return, while its 1 year total shareholder return of 19.1% points to...

In early January 2026, Permian Resources Corporation filed new universal shelf registrations covering Class A common stock, preferred stock and warrants, while also closing several prior employee stock ownership plan (ESOP) related shelves and withdrawing a 2024 omnibus shelf. Alongside these filings, the company completed a corporate reorganization and saw multiple senior executives sell shares, some to cover tax obligations from vested performance stock, reshaping its capital structure and...

Corewell Health and Quest Diagnostics recently completed their Diagnostic Lab of Michigan joint venture, giving Quest 51% ownership and extending its Collaborative Lab Solutions across 21 Corewell hospitals, with a new facility planned for early 2027. This majority-owned partnership meaningfully deepens Quest’s hospital footprint in Michigan, potentially reinforcing its role as an outsourced lab partner for large health systems. We’ll now examine how this expanded Corewell partnership, and...

In recent days, Dash Social announced a partnership making it an Official Snapchat Partner, allowing brands to publish directly to Snapchat and access real-time, API-sourced analytics, while Snap also reported quarterly results that exceeded analyst expectations and issued strong guidance for the following quarter. Together with the appointment of technology executive Matthew McRae to Snap’s board and CEO Evan Spiegel’s pre-planned share sale of about US$10,000,000, these developments...

In recent years, H.B. Fuller’s return on capital employed has risen to 8.3%, while the capital base expanded by 27%, highlighting stronger operational efficiency and reinvestment. This combination of higher returns and greater capital employed suggests the company is finding more productive ways to reinvest internally, which may not yet be fully appreciated in the market. We’ll now explore how H.B. Fuller’s improving return on capital employed reshapes its existing investment narrative and...

On January 7, 2026, Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments (CLOV), sold 2,102 shares, adding to a wider pattern of insider selling that some investors may want to watch. See our latest analysis for Clover Health Investments. Clover Health Investments’ share price, which last closed at US$2.53, has seen a 7.7% 7 day share price return and a 5.0% year to date share price return. Its 1 year total shareholder return reflects a 30.5% loss, suggesting recent momentum...

If you are wondering whether Rocket Lab's current share price reflects its true worth, this article walks through what the numbers actually say about value. Rocket Lab's share price recently closed at US$83.08, with returns of 19.1% over 7 days, 55.5% over 30 days, 9.3% year to date and 203.7% over 1 year, and a very large return over 3 and 5 years. These sharp moves have kept Rocket Lab on many investors' watchlists, as the stock reacts to ongoing developments around its business and...

If you are wondering whether Centene's current share price reflects its underlying value, you are not alone. This article will help you frame that question clearly. Centene's stock recently closed at US$46.92, with returns of 14.0% over 7 days, 23.2% over 30 days, 12.3% year to date, but with a 25.7% decline over 1 year, a 40.0% decline over 3 years, and a 27.8% decline over 5 years. These mixed return figures have put renewed attention on how the market is currently assessing managed care...

If you are wondering whether Halliburton’s current share price lines up with its underlying worth, this breakdown will help you see how the numbers stack up. Halliburton shares last closed at US$32.63, with returns of 10.2% over the past week, 12.4% over the last 30 days, 10.2% year to date and 24.6% over the past year, while the 3 year return is an 18.1% decline and the 5 year return is 72.2%. Recent news flow around Halliburton has continued to focus on its role as a major U.S. oilfield...

Knight-Swift Transportation Holdings Inc. has appointed Soumit Roy as executive vice president, General Counsel and Corporate Secretary, effective December 31, 2025, following the retirement of Todd Carlson. The leadership change in the legal and governance function comes as analysts highlight Knight-Swift’s scale, efficiency focus, and exposure to a potential truckload recovery, underscoring the importance of execution and risk management. With analysts increasingly optimistic about a...

Why Stewart Information Services is on investors’ radar With Stewart Information Services (STC) posting annual revenue of US$2,796.513 million and net income of US$101.999 million, investors are weighing how this scale of earnings power lines up with recent share price moves. See our latest analysis for Stewart Information Services. At a share price of US$68.15, Stewart Information Services has experienced short term pressure, with a 1 month share price return of 5.92% and a year to date...

Taylor Morrison Home (TMHC) has just been named America's Most Trusted Home Builder for the eleventh straight year, with its 2026 Net Trust Score improving 5.6 points from 2025. For shareholders, that recognition raises fresh questions about how the company's current valuation lines up with its brand strength and recent share performance. See our latest analysis for Taylor Morrison Home. The trust award comes at a time when Taylor Morrison Home's share price has been relatively firm. A 1-day...

If you are wondering whether Lumentum Holdings still offers good value after its recent strong performance, or if the price has already moved ahead of the underlying story, this article walks through what the current share price might be implying. The stock has pulled back recently, with a 5.5% decline over the last week and a 3.3% decline over the last month. It still shows a 9.8% decline year to date, alongside very large 1 year and multi year returns that may catch your eye. Recent...

BioCryst Pharmaceuticals (BCRX) has drawn investor attention after recent share price moves, with the stock last closing at US$7.62. For a rare disease focused biotech, that puts current performance and ongoing drug development firmly in focus. See our latest analysis for BioCryst Pharmaceuticals. Recent trading has been a bit choppy, with a 1 day share price return of a 3.79% decline and a 7 day share price return of a 2.31% decline, while the 90 day share price return of 5.54% contrasts...

CONMED Corporation recently announced that Chief Financial Officer Todd Garner will step down by March 15, 2026, while staying on as an advisor through November 2, 2026, and at the same time reaffirmed its full-year 2025 consolidated revenue and adjusted EPS guidance originally issued in November 2025. A key detail for investors is that CONMED stated Garner’s planned departure is unrelated to any disagreement over the company’s financial statements or disclosures, aiming to limit concerns...

International Flavors & Fragrances recently reported quarterly revenue of US$2.69 billion, a 7.9% decline year on year, while still exceeding analyst expectations on both organic sales and EBITDA performance. Healthy accounts receivable trends and stable days sales outstanding, alongside an analyst upgrade reflecting increased confidence in the business, highlight that recent operational execution may be more resilient than headline revenue declines suggest. We’ll now examine how this...

In recent days, eBay has faced renewed scrutiny as its active buyer base has remained flat at 134 million for two years, while its EBITDA margin has contracted by 3.5 percentage points and payment processing glitches have frustrated some UK sellers. At the same time, the rapid resale of discontinued New York City MetroCards as collector's items on eBay highlights the platform's enduring role as a marketplace for niche, high-demand memorabilia even as growth and profitability questions...

Cytokinetics recently faced a shareholder rights investigation by Grabar Law Office over allegations that it made misleading statements about the FDA’s review of its aficamten filing, including issues around a potential Risk Evaluation and Mitigation Strategy. This legal scrutiny adds another layer of regulatory and governance risk around aficamten at a time when the company’s late-stage pipeline is central to its outlook. We’ll now examine how this shareholder investigation into disclosures...

What sparked the latest interest in Motorola Solutions stock? Piper Sandler’s recent upgrade of Motorola Solutions (MSI), coupled with positive commentary on its mission critical communications business, has put fresh attention on a stock backed by solid sales growth and strong free cash flow. See our latest analysis for Motorola Solutions. Beyond the analyst upgrade, Motorola Solutions has seen a mixed share price pattern, with a 1-day share price return of 1.17% but a 90-day share price...

If you are wondering whether Topgolf Callaway Brands is attractively priced or not, this article will walk you through what the current share price could imply about value. The stock has been active recently, with a 16.4% return over 7 days, 19.6% over 30 days, 15.9% year to date and 57.2% over the last year, while the 3 year and 5 year returns of 39.0% and 49.8% declines show a very different experience for longer term holders. These recent moves sit against a backdrop of ongoing interest...

If you are wondering whether Allstate's current share price lines up with its underlying worth, you are not alone. That is exactly what this article is here to unpack. Allstate shares last closed at US$211.10, with returns of 1.4% over 7 days, 5.0% over 30 days, 3.6% year to date, 12.2% over 1 year, 65.2% over 3 years and 118.9% over 5 years. This raises fair questions about how much value is now priced in and how much risk investors are taking on at these levels. Recent attention on...

If you are wondering whether MongoDB's share price still reflects good value or has run ahead of itself, looking closely at how it is priced today can help you set expectations before you commit fresh capital. The stock recently closed at US$413.52, with a 1.5% decline over the last 7 days, a roughly flat 0.1% decline over 30 days, and returns of 3.5% year to date and 66.3% over the past year. The 3 year and 5 year returns sit at 116.9% and 13.5% respectively. Recent attention on MongoDB has...

Sidus Space has appointed veteran aerospace and defense executive Kelle Wendling to its Board of Directors, while former members Dana Kilborne and Cole Oliver have concluded their service and Tiffany Norwood has become Chair of the Audit Committee. Wendling’s decades of experience leading complex space systems and government contracting programs at L3Harris bring deep operational and oversight expertise to Sidus Space’s boardroom. With these boardroom shifts and Wendling’s extensive...